At the same time, based on PCs protecting ECs against angiogenic drugs, tyrosine kinase inhibitors which eliminate PDGFRβ-positive PCs combined with VEGF inhibitors are more effective at blocking tumor angiogenesis than anti-VEGF alone [305]. The gene discussed is VEGFA; the disease is neoplasm.